MedPath

Spinal Metastasis as the First Presentation of Lung Malignancy: Clinical Characteristics and Postoperative Survival

Completed
Conditions
Lung Cancers
Bone Metastasis
Registration Number
NCT07100444
Lead Sponsor
Guangdong Provincial People's Hospital
Brief Summary

The aim of this study is to compare the clinical features and postoperative survival outcomes between patients with spinal metastasis as the initial manifestation of malignancy and those with spinal metastasis occurring after an established diagnosis of malignancy.

Detailed Description

The aim of this study is to compare the clinical features and postoperative survival outcomes between patients with spinal metastasis as the initial manifestation of malignancy and those with spinal metastasis occurring after an established diagnosis of malignancy. By analyzing and contrasting these two groups, we seek to identify any distinctive characteristics, prognostic factors, and potential implications for early detection and treatment strategies in patients with malignant spinal metastases.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
139
Inclusion Criteria
  1. Age ≥ 18 years.
  2. Pathologically or radiologically confirmed diagnosis of lung cancer with spinal metastasis.
  3. Patients with spinal metastasis who underwent surgical intervention.
  4. Adequate medical records and follow-up data available.
Exclusion Criteria
  1. Patients with spinal metastasis originating from non-lung primary tumors.
  2. Patients who did not receive surgical treatment for spinal metastasis.
  3. Incomplete clinical data or lost to follow-up.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postoperative Overall SurvivalFrom the date of surgery until death or last follow-up, up to 5 years

Postoperative overall survival is defined as the time from the date of surgery for spinal metastasis to the date of death from any cause. Patients who are still alive at the last follow-up will be censored at that date. Survival status will be ascertained by clinical follow-up and/or review of medical records.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Guangdong Provincial People's Hospital

🇨🇳

Guangzhou, Guangdong, China

Guangdong Provincial People's Hospital
🇨🇳Guangzhou, Guangdong, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.